Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06311799 · ClinicalTrials.gov registry record · NA

Advancing Health Equity by Integrating Social-Clinical Models During Pregnancy

A NA study, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
240
Enrollment target

NCT06311799: Completed NA study, sponsored by Geisinger Clinic.

NCT06311799 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06311799, a NA study, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
240 participants
Enrollment target

Study Summary

This study is being done to find out if online referrals to a food management program for Women, Infants, and Children (WIC) made by clinical teams will get more people to enroll in WIC. Women aged 18 or older who get healthcare at Geisinger, are pregnant, and are eligible to be referred to the WIC program will be recruited. These women need to consent to join this study. There are four groups in this study. Group 1 will get usual care with details about WIC from their clinical team. Group 2 will be sent to WIC by their clinical team. The study team may help the clinical team with the referrals. Group 3 will get details about WIC from their clinical team and a dietitian will talk to them about heart-healthy diets and food management. Group 4 will be sent to WIC by their clinical team or study team and a dietitian will talk to them about heart-healthy diets and food management. Participants who talk with the dietitians will be sent kitchen utensils based on need. This study will last about 18 months and will have 240 total subjects joining at about 60 per month. Each subject will be in the study for about 6 months. Subjects will be asked to complete surveys at the start and end of the study. Some subjects will also be asked about their experience in the study after they are done.

Primary Outcome

Difference in WIC enrollment between Arm 1 and Arm 3 (Information only) vs Arm 2 and Arm 4 (digital connections)

Interventions

  • BEHAVIORAL WIC Referral
  • BEHAVIORAL RDN Referral

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2024-04-29
Est. Completion 2025-12-31
Phase NA
Geisinger Clinic

107 total trials

What the finished NCT06311799 record still lists

NCT06311799 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 2 interventions - of which WIC Referral is the first listed.

NCT06311799 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06311799 about?

NCT06311799 is a clinical study titled "Advancing Health Equity by Integrating Social-Clinical Models During Pregnancy". This study is being done to find out if online referrals to a food management program for Women, Infants, and Children (WIC) made by clinical teams will get more people to enroll in WIC. Women aged 18 or older who get healthcare at Geisinger, are pregnant, and are eligible to be referred to the WIC ...

What is the current status of trial NCT06311799?

This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2024-04-29. Estimated completion is 2025-12-31.

What interventions are being tested in trial NCT06311799?

The interventions under investigation include: WIC Referral (BEHAVIORAL), RDN Referral (BEHAVIORAL).

Who is sponsoring clinical trial NCT06311799?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06311799's enrollment target sits among peer trials

240 440th of 2000 higher than 1,542 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06311799, the US trial registry maintained by the National Library of Medicine. NCT06311799 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.